Clinical Trials Logo

Intracranial Hypertension clinical trials

View clinical trials related to Intracranial Hypertension.

Filter by:

NCT ID: NCT04314128 Completed - Clinical trials for Idiopathic Intracranial Hypertension

Assessment of ICP in Idiopathic Intracranial Hypertension Using Transocular Ultrasound and Transcranial Doppler

Start date: January 1, 2020
Phase: N/A
Study type: Interventional

Idiopathic Intracranial Hypertension (IIH) is a rare disease, primarily affecting overweight females of child-bearing age. Patients suffer from increased intracranial pressure (ICP), typically resulting in headaches, visual disturbances and bilateral papilledema, pulsatile tinnitus and cognitive deficits. The disease is difficult to diagnose, treat and monitor. The only current method of measuring the ICP in day-to-day clinical practice is by lumbar puncture. This procedure is invasive, and often painful for the patient. There is an unmet need of methods that can reliable measure or estimate ICP in a non-invasive manner. Ultrasound is one such potential method, and the aim of this study is to investigate the use of ocular ultrasound and transcranial doppler to measure or estimate ICP.

NCT ID: NCT04224532 Completed - Pneumoperitoneum Clinical Trials

The Effect of Pneumoperitoneum Timing on Intracranial Pressure in Laparoscopy

Start date: January 8, 2020
Phase: N/A
Study type: Interventional

Reverse Trendelenburg position has been shown to slightly reduce the intracranial pressure associated with pneumoperitoneum. However, there are no studies on the effect of the timing of reverse Trendelenburg position on intracranial pressure. This study will monitor the effect of reverse Trendelenburg position before or after pneumoperitoneum on intracranial pressure and regional cerebral oxygen saturation.

NCT ID: NCT04207229 Completed - Hydrocephalus Clinical Trials

CERTAS Programmable Valve Registry

CERTAS
Start date: November 21, 2019
Phase:
Study type: Observational [Patient Registry]

Post-Market Clinical Follow-up Registry of Patients with CODMAN CERTAS Plus Programmable Valves.

NCT ID: NCT04188353 Completed - Clinical trials for Raised Intracranial Pressure

Effect of Intravenous Administration of Mannitol on ONSD in Patients With Raised ICP

Start date: February 24, 2019
Phase:
Study type: Observational

Osmotherapy with mannitol has been a common practice in patients with raised ICP. Monitoring its effect on ICP can be performed invasively and non-invasively. Due to a validated correlation between invasive ICP monitoring and ONSD measurement, it can be a tool to monitor acute and long term effects of osmotherapy non-invasively on ICP. This study examines the acute changes in sonographically measured ONSD brought about by the administration of mannitol. This can correlate with the changes in ICP in such patients and can be utilized as a tool for decision making/ point-of-care utility.

NCT ID: NCT04004923 Completed - Clinical trials for Intracranial Pressure Increase

Intracranial Pressure in Monopolar and Bipolar Hysteroscopy

Start date: July 5, 2019
Phase: N/A
Study type: Interventional

Two distinction fluids are used in operative hysteroscopy. One is monopolar and the second is bipolar. The monopolar fluid contains mannitol and the bipolar fluid contains serum physiologic. This study aims to compare intracranial pressure in patients undergoing monopolar and bipolar hysteroscopy.

NCT ID: NCT03963336 Completed - Clinical trials for Idiopathic Intracranial Hypertension

Quantitative D-dimer Level and Anticoagulant Therapy in Idiopathic Intracranial Hypertension

Start date: July 22, 2017
Phase: Early Phase 1
Study type: Interventional

Idiopathic intracranial hypertension (IIH) is a syndrome characterized by elevated intracranial pressure (ICP) of unknown etiology. The investigators aim to study the quantitative D-dimer level and the role of anticoagulant therapy in the absence of occlusive sinus thrombosis in IIH patients.

NCT ID: NCT03957837 Completed - Clinical trials for Intracranial Hypertension

Optical Nerve Sheath Changes During Head Down Laparoscopy

Start date: May 13, 2019
Phase:
Study type: Observational

Patient undergoing laparoscopic radical prostatectomy in steep trendelenburg position are at risk to develop complication from brain edema. Ultrasound assessment of optical nerve sheath diameter is a simply, non-invasive method to estimate the increase of intracranial pressure. It is unknown how optical nerve sheath diameter changes after prolonged head down position.

NCT ID: NCT03867461 Completed - Clinical trials for Idiopathic Intracranial Hypertension

The Effects of MAP and EtCO2 on Venous Sinus Pressures

Start date: June 20, 2019
Phase: N/A
Study type: Interventional

The purpose of this study is to further elaborate the role of both arterial blood pressure and end-tidal carbon dioxide concentration on measured venous pressures.

NCT ID: NCT03782077 Completed - Clinical trials for Intracranial Pressure Increase

Change of Optic Nerve Sheath Diameter After Deflation of Pneumatic Tourniquet

Start date: November 15, 2018
Phase:
Study type: Observational

The purpose of this study is to evaluate the change of the optic nerve sheath diameter after deflation of pneumatic tourniquet.

NCT ID: NCT03641443 Completed - Clinical trials for Intracranial Pressure Increase

non_invasive_aICP_Tumor

aICPTumor
Start date: September 12, 2016
Phase: N/A
Study type: Interventional

Since decades, neurosurgeons and neurooncologists assumed that the mass effect of brain tumors with peritumoral edema or intratumoral hemorrhage might lead to increased ICP. Therefore, decisions on surgical procedures and medical treatments were made based on clinical and radiological findings suggesting increased ICP. But in fact, no measurement has ever confirmed increased ICP in brain tumor patients. From an ethical point of view, it is not justifiable to implant an intraparenchymal ICP probe within an invasive surgical procedure in a brain tumor patient unless the patient is comatose or present with rapid impairment of the level of consciousness. Therefore, with the new medical device for non-invasive ICP measurement presented in this study protocol, we will be able to measure absolute ICP values in patients with brain tumors.